002940 Stock Overview
A pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.51 |
| 52 Week High | CN¥22.59 |
| 52 Week Low | CN¥11.82 |
| Beta | -0.021 |
| 11 Month Change | -5.44% |
| 3 Month Change | -26.97% |
| 1 Year Change | -32.78% |
| 33 Year Change | -14.24% |
| 5 Year Change | -15.70% |
| Change since IPO | -20.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002940 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.9% | 0.05% | -1.6% |
| 1Y | -32.8% | -11.8% | -19.6% |
Return vs Industry: 002940 underperformed the CN Pharmaceuticals industry which returned -11.8% over the past year.
Return vs Market: 002940 underperformed the CN Market which returned -19.6% over the past year.
Price Volatility
| 002940 volatility | |
|---|---|
| 002940 Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 002940's share price has been volatile over the past 3 months.
Volatility Over Time: 002940's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 981 | Guo Zheng | www.alkpharm.com |
Zhejiang AngLiKang Pharmaceutical CO.,LTD., a pharmaceutical company, engages in manufacturing APIs and pharmaceutical preparations for oral cephalosporins, cardiovascular, and kidney diseases. The company also offers products in the areas of anti-infection, antihypertensive, digestive system, central nervous diseases, and respiratory preparations. The company was founded in 2001 and is based in Shengzhou, China.
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Fundamentals Summary
| 002940 fundamental statistics | |
|---|---|
| Market cap | CN¥2.50b |
| Earnings (TTM) | CN¥152.42m |
| Revenue (TTM) | CN¥1.71b |
16.4x
P/E Ratio1.5x
P/S RatioIs 002940 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002940 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.71b |
| Cost of Revenue | CN¥825.68m |
| Gross Profit | CN¥882.26m |
| Other Expenses | CN¥729.84m |
| Earnings | CN¥152.42m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Aug 28, 2024
| Earnings per share (EPS) | 0.76 |
| Gross Margin | 51.66% |
| Net Profit Margin | 8.92% |
| Debt/Equity Ratio | 26.1% |
How did 002940 perform over the long term?
See historical performance and comparison